MENU
  • PEOPLEOur Team
  • PORTFOLIOCompanies
  • IMPACTDisclosure
  • WELLNESSOur Fund
  • SIIFICAbout us
  • CONTACTSubmit Pitch
SIIF Impact Capital, Inc.
〒107-0062
3-1-3, Minami Aoyama, Minato-ku, Tokyo, JAPAN
Purposeful Capital Powerful Change | SIIF Impact Capital, Inc.
SIIF Impact Capital, Inc.
  • PEOPLEOur Team
  • PORTFOLIOCompanies
  • IMPACTDisclosure
  • WELLNESSOur Fund
  • SIIFICAbout us
  • CONTACTSubmit Pitch
SIIF Impact Capital, Inc.
  • PEOPLEOur Team
  • PORTFOLIOCompanies
  • IMPACTDisclosure
  • WELLNESSOur Fund
  • SIIFICAbout us
  • CONTACTSubmit Pitch
  1. ホーム
  2. BLOG
  3. System Mapping: ORTHOREBIRTH

System Mapping: ORTHOREBIRTH

2024 6/03
BLOG
2024年6月3日

Harnessing the Power of AI in System Mapping

SIIFIC partnered with Orthorebirth in March 2024. Orthorebirth, founded in June 2011, is a medical device startup, renowned for its flagship product, the cottony-type, synthetic bone-void-filling material “ReBOSSIS.”

With this funding, Orthorebirth aims to develop a drug that promotes bone formation using Bone Morphogenetic Protein (BMP). Although this project might initially seem understated, SIIFIC’s impact due diligence (Impact DD) has highlighted its significant potential. In this Impact DD, SIIFIC incorporated new initiatives leveraging AI, building on the experience from the first investment.

J-Pharma System Map Arouses Engaging Responses

Nanako: Our first investment, J-Pharma, is developing a drug that maintains the quality of life (QOL) for terminal cancer patients. When we introduced the Impact DD for this investment on our blog, we received unexpected responses, didn’t we?

Kazu

Yes, we received a feedback from our reader who lost both her parents to cancer. Although she is not our investor nor invest, she read our blog and wrote to us, “I saw the system map on your blog and it made me cry.”

Kazu

“Emotionless medical care” loop in the bottom left of this map represented her real experience. She said, “Doctors were constantly looking at laptop screens instead of patients, following treatment guidelines without any empathy.” The map mentions “aiming for medical care that gives hope til the last moment,” which deeply resonated with her and moved her to tears.
I’m a 20 years healthcare investment veteran, but this was the first time I received feedback from end beneficiaries. The fact that our meticulously crafted system map resonated with her and others made us incredibly happy and moved us to tears as well.

Nanako: The goal of investment is to reach the end beneficiaries, but receiving direct feedback from them is indeed rare.

Kazu

The system map clarified the unique features of J Pharma and the drug. One such feature was the “physician satisfaction rate” set as a short-term impact KPI. Being able to prescribe a drug with minimal side-effect to terminal cancer patients, who previously had no such option, provides physicians with a sense of purpose and satisfaction.

Nanako Kudo: By conceptualising cancer treatment challenges as a system, we were able to focus on both patients and healthcare providers.

Reiri

Through this exercise of System Mapping, we clearly distinguished between business KPIs and impact KPIs. Here, one of the business KPIs will be “the number of patients treated with the drug” In contrast, the impact KPIs will be “physician satisfaction rate” and “improved leisure time for patients,” which qualitatively differ from and often trade off against business KPIs. This distinction solidified our understanding of impact investing.

Discovering Solutions to Social Issues in Bone Healing

Nanako: Can you tell me meow about Orthorebirth?

Kazu

Orthorebirth is a company in the orthopaedic field, developing, manufacturing, and selling synthetic bone “ReBOSSIS”. They are currently developing a drug containing Bone Morphogenetic Protein (BMP), which promotes bone formation. BMP is already approved in countries like the United States.

Source: Orthorebirth Website

Nanako Kudo: You mentioned that this is a relatively understated field.

Kazu

Compared to cutting-edge technologies like regenerative medicine and AI, it might not attract much attention. Initially, we struggled with how to approach this. However, while gathering data, we focused on the issue of caregiving, a major issue in aging country like Japan.
The top three causes of long-term care are dementia, cerebrovascular disease (stroke), and fracture/fall. Elders who fracture bones take a long time to heal, reducing their activity levels, leading to cognitive and physical decline, eventually requiring care. In Japan, where the population is rapidly aging, fractures are a major social issue.
BMP can speed up bone formation, avoiding the need to harvest bone from other parts of the body, thus reducing treatment risks and damage. Patients can start rehabilitation sooner, decreasing the likelihood of becoming bedridden.

Source: Ministry of Health, Labour and Welfare, Comprehensive Survey of Living Conditions 2022

Reiri

This aligns with SIIF’s Healthcare Vision Paper, depicted in our “Healthcare Issue Map – Elderly.” We integrated elements from this map into Orthorebirth’s system map and updated it.

Harnessing the Power of AI in System Mapping

Nanako: You also refined the method for creating the system diagram based on the first investment’s experience.

Kazu

While creating the system map for J Pharma, we wondered if our method of identifying elements, or more specifically variables, might be biased. Although we interviewed many people to identify these variables the choice of interviewees and the interviews themselves were conducted by us, which might have introduced bias.
To avoid this bias, we considered web scraping, extracting and collecting data from the web. With help from AI engineers, we learned that AI such as ChatGPT could perform web scraping. Working with the engineers, we developed an optimal prompt. This led to the discovery of the overlooked variable “pain.”
Physicians often say, “Pain can be controlled with medication, so it’s not an issue.” However, patients still experience pain, which can prevent them from sleeping, leading to weakness. AI helped us identify this crucial variable.

Nanako: You mentioned concerns about bias beyond variable extraction.

Kazu

Yes, we were also concerned about where to place variables within the map. As long as we arranged them based on our thinking, we tended to position them in a way that suited us. We sought advice from experts in mathematics and physics to objectively calculate the coordinates for these variables. They suggested using co-occurrence analysis.
Co-occurrence analysis identifies pairs of words frequently used together, indicating their closeness. We applied this to arrange variables that should be positioned close together in the system diagram.
For example, in our fund’s Theory of Change (ToC), we identified two leverage points “wellness literacy” and “social capital.” These variables, crucial to our investment themes and deal sourcing, should appear in the system map.
Initially, we placed these two variables at opposite ends of the map, thinking it was easier to address challenges from two leverage points. However, co-occurrence analysis revealed their close relationship, prompting a significant redesign of the system diagram.
After completing the system map, we met with Orthorebirth’s management. We explained, “Based on our research and analysis, we believe your product can improve fracture treatment in the elderly and prevent them from becoming bedridden, thus addressing caregiving issues.” Their enthusiasm was palpable as they began passionately discussing their product’s mission, leading to the new keyword “social pain.”

Nanako: What does “social pain” mean?

Kazu

When the elderly require care, it gives rise to issues like caregiver resignation and young carers. Orthorebirth’s CEO termed this “social pain.” He said, “Our goal is to alleviate not only physical pain but also social pain through our research and development.” We incorporated this philosophy into the final system map.

Insights Gained from Creating System Maps

Nanako: What improvements or goals do you have for the next investment?

Kazu

For Orthrebirth, we thoroughly avoided bias by scraping the entire web. However, some level of bias might be necessary. For the next investment, we plan to input all related texts, including interviews and business content, into AI and see how it learns from this database.

Reiri

Engaging deeply with the founders and management of investee companies is essential. In both investments, their words gave us the hints for impact KPIs. When we identified keywords like “physician satisfaction” or “social pain,” their facial expressions noticeably changed. They transitioned from a professional to a person passionate about the issue they are tackling. They enthusiastically and eloquently told us their sense of purpose and mission. We believe similar insights will emerge with future investees.

Nanako: It’s fascinating that a system map, created objectively and with AI assistance to eliminate bias, can evoke engagement and inspire vision and ideas. What does this mean?

Reiri

When creating a system map we should depict the current state rather than make value judgments, allowing for an honest engagement with the issues.

Nanako: Do you think this aligns well with the fund’s Theory of Change?

Kazu

Yes, every investment’s system map includes “wellness literacy” and “social capital.” As we continue to build our portfolio, we will understand holistic wellness system better

関連記事

【登壇報告】Triple Iセミナーに代表パートナーの三浦が登壇しました
 2025年4月16日
Reiri Miura Speaks at Triple I Global Health Seminar
 2025年4月16日
日本発VCが挑む「インパクトの可視化」- SIIFIC国際基準OPIMに基づく第2回ディスクロージャーを公開
 2025年4月8日
「誰もがよりよく生きられる社会」SIIFICがインパクト・パフォーマンス・レポート2025を公開。測定前でも“見える”インパクトとは?
 2025年4月1日
SIIFIC Wellness Fund Invests in Proximar Ltd. 
 2025年3月25日
SIIFIC 肥後銀行の出資を受けファンド規模が35億円を突破
 2024年11月15日
SIIFIC Wellness Fund Raises ¥500 Million from Higo Bank bringing total fund size to over ¥3.5 Billion
 2024年11月15日
日経バイオテク に掲載されました
 2024年8月28日
J Pharma Receives Prestigious AMED Grant
 2024年7月3日
Signing the Impact Principles: Part 2 "Disclosure Statement" and "Independent Verification"
 2024年6月5日
BLOG
Drug impact investing Medical Device Orthorebirth
  • 2024年5月16日「Social Impact Day 2024」に登壇
  • Signing the Impact Principles: Part 1 Conditions and Benefits

© SIIF Impact Capital, Inc.

PAGE TOP